GeneDx Holdings Corp.
$79.92
(as of Jun 23, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for GeneDx Holdings Corp.
Stock Price
$79.92
Ticker Symbol
WGS
Exchange
NASDAQ
Industry Information for GeneDx Holdings Corp.
Sector
Healthcare
Industry
Diagnostics & Research
Company Description for GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
Fundamentals for GeneDx Holdings Corp.
Market Capitalization
$1,918,179,584
EBITDA
$8,846,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-1.39
Earnings per Share Estimate Next Year
Profit Margin
-11.69%
Shares Outstanding
28,531,600
Percent Owned by Insiders
12.70%
Percent Owned by Institutions
86.65%
52-Week High
52-Week Low
Technical Indicators for GeneDx Holdings Corp.
Analyst Ratings for GeneDx Holdings Corp.
Strong Buy
3
Buy
0
Hold
3
Sell
0
Strong Sell
0
News About GeneDx Holdings Corp.
Jun 23, 2025, 5:06 PM EST
In trading on Monday, shares of GeneDx Holdings Corp (Symbol: WGS) crossed above their 200 day moving average of $73.76, changing hands as high as $80.50 per share. See more.
Jun 23, 2025, 4:31 PM EST
[Digital DNA. See more.
Jun 23, 2025, 3:55 PM EST
Investing.com -- GeneDx Holdings Corp (NASDAQ:WGS) stock surged 18.5% after the American Academy of Pediatrics (AAP) issued updated guidance recommending exome and genome sequencing as first-tier tests for children with global developmental delay or intellectual disability.
See more.
Jun 23, 2025, 3:17 PM EST
-- A milestone in pediatric medicine, general pediatricians are now expected to play a more active role in initiating genetic testing --
See more.